Abstract
Surveillance radioiodine whole body scans have been used for many years in the follow-up of patients with differentiated thyroid cancer. However, the term “surveillance whole body scan” has been used in different ways. This chapter (1) differentiates surveillance scans from baseline scans and pre-therapy scans, (2) presents the objectives of surveillance scans, (3) presents an overview of the guidelines of various organizations for the utility of surveillance scans, and (4) presents a proposed guideline for the use of surveillance scans.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cailleux AF, Baudin E, Travagli JP, Schlumberger RM. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? J Clin Endocrinol Metab. 2000;85:175–8.
Wartofsky L. Management of low risk well differentiated thyroid cancer based only upon thyroglobulin measurement after recombinant human thyrotropin. Thyroid. 2002;12:583–92.
Mazzaferri EL, Kloos RT. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation? J Clin Endocrinol Metab. 2002;87:1490–8.
Wartofsky L. Using baseline and recombinant human TSH-stimulated Tg measurements to manage thyroid cancer without diagnostic I-131 scanning. J Clin Endocrinol Metab. 2002;87:1486–9.
Pacini F, Capezzone M, Elisei R, et al. Diagnostic 131-iodine whole body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. J Clin Endocrinol Metab. 2002;87:1499–501.
Fatemi S, Nicoloff J, Lo Presti J, Spencer S. TSH-stimulated serum thyroglobulin in the 1–10 ng/ml range suggests a low long-term recurrence risk for papillary thyroid cancer (PTC). Washington, DC: Program of the 73rd annual meeting of the American Thyroid Association, 2001, 290 (Abstract 194).
Pacini F, Molinaro E, Lippi F, et al. Prediction of disease status by recombinant human TSH-stimulated serum thyroglobulin in the post surgical follow-up of differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2001;86:5686–90.
American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer, Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133.
Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JWA, Wiersinga W, the European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006;154:787–803.
National Comprehensive Cancer Network (NCCN) Clinical practice guidelines in oncology. thyroid carcinoma. Follicular Thyroid Carcinoma. V.2.2015.
British Thyroid Association and Royal College of Physicians. Guidelines for the management of thyroid cancer. 2nd ed. Available at: http://www.british-thyroid-ssociation.org/news/Docs/Thyroid_cancer_guidelines_2007.pdf.
de Meer S, Vriens MR, Zelissen PM, Borel Rinkes IH, de Keizer B. The role of routine diagnostic radioiodine whole-body scintigraphy in patients with high-risk differentiated thyroid cancer. J Nucl Med. 2011;52:56–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this chapter
Cite this chapter
Van Nostrand, D. (2016). Surveillance Radioiodine Whole Body Scans. In: Wartofsky, L., Van Nostrand, D. (eds) Thyroid Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3314-3_41
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3314-3_41
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-3312-9
Online ISBN: 978-1-4939-3314-3
eBook Packages: MedicineMedicine (R0)